EVMN R&D to Revenue
Evommune, Inc. Common Stock · R&D to Revenue
EVMN R&D to Revenue
Latest reported0.00%period ending
EVMN Quarterly R&D/Revenue (113.53% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
EVMN r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 196.39% | |
| 0% | |
| 478.7333% | |
| 0% | |
| 0% | |
| 0% | |
| 113.5286% |